MyFinsight
Home
About
Contact
snoa: the income statement
Download
Download image
Comprehensive loss
-$329K
(72.65%↑ Y/Y)
Foreign currency
translation adjustments
$205K
(134.57%↑ Y/Y)
Net loss
-$534K
(12.46%↑ Y/Y)
Income tax benefit
(expense)
-$197K
(-234.01%↓ Y/Y)
Net loss before
income taxes
-$731K
(-57.88%↓ Y/Y)
Revenues
$5,604K
(56.58%↑ Y/Y)
Other (expense)
income, net
-$394K
(-201.81%↓ Y/Y)
Loss from operations
-$337K
(60.35%↑ Y/Y)
Gross profit
$2,120K
(55.77%↑ Y/Y)
Cost of revenues
$3,484K
(57.08%↑ Y/Y)
Total operating
expenses
$2,457K
(11.13%↑ Y/Y)
Selling, general and
administrative
$1,882K
(10.38%↑ Y/Y)
Research and development
$575K
(13.64%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Sonoma Pharmaceuticals, Inc. (SNOA)
Sonoma Pharmaceuticals, Inc. (SNOA)